FDA Person
FDAKimberly L. Schultz
View detailed information about Kimberly L. Schultz, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 2 inspections of 2 companies, 2019–2023.
Inspections (2)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| December 6, 2023 | Carsgen Therapeutics Corporation | Not classified | #1226414 | |
| August 21, 2019 | Novartis Pharmaceuticals Corporation | VAI | Human Cellular, Tissue, and Gene Therapies | #1100101 |
Documents (6)
- EIR · Bristol-Myers Squibb Company · February 19, 2021
- EIR · Novartis Pharmaceuticals Corporation · August 21, 2019
- EIR · Minaris Regenerative Medicine, LLC · April 26, 2017
- 483 · Carsgen Therapeutics Corporation · December 6, 2023
- 483 · Bristol-Myers Squibb Company · February 19, 2021
- 483 · Novartis Pharmaceuticals Corporation · August 21, 2019
Frequently inspected with (5)
Person Information
Name
Kimberly L. Schultz
Title
investigator
Role
COMPANY REP
ID: 2d000290-f49c-4cfd-b8f8-3f4d71f76324
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.